Related Experiment Video

Updated: Feb 13, 2026

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

2.3K

Current status of immunotherapy and immune biomarkers in gastro-esophageal cancers

Nischala Ammannagari1, Ajlan Atasoy1

  • 1Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA.

Journal of Gastrointestinal Oncology
|March 23, 2018
PubMed

Insights

Gastroesophageal cancer immunotherapy shows promise, but identifying biomarkers is crucial for effective treatment. Further research is needed to overcome challenges posed by tumor heterogeneity and improve patient outcomes.

Area of Science:

  • Oncology
  • Immunotherapy
  • Gastroesophageal Cancer Research

Background:

  • Gastroesophageal cancers represent a significant global health burden with poor prognoses for advanced stages.
  • While immunotherapy has revolutionized cancer treatment, its efficacy varies, necessitating biomarker identification.
  • The molecular and immunological heterogeneity of gastroesophageal cancers complicates the tumor microenvironment and response assessment.

Purpose of the Study:

  • To highlight the need for novel therapeutic strategies in gastroesophageal cancers.
  • To review current data on the efficacy of immune checkpoint inhibitors in this context.
  • To discuss the critical role of biomarkers in predicting and guiding immunotherapy response.

Main Methods:

  • Review of emerging immunotherapy data in gastroesophageal cancers.
  • Analysis of challenges in biomarker discovery due to tumor heterogeneity.
  • Discussion of immune checkpoint inhibitor activity and biomarker utility.

Main Results:

  • Immunotherapy, particularly checkpoint inhibitors, is an emerging treatment modality for gastroesophageal cancers.
  • Tumor heterogeneity presents a significant challenge for identifying reliable biomarkers.
  • Biomarker research is essential for personalizing immunotherapy and improving treatment efficacy.

Conclusions:

  • New therapeutic approaches are urgently needed for gastroesophageal cancers.
  • Understanding biomarkers is key to unlocking the full potential of immunotherapy.
  • Further investigation into immunotherapy and biomarkers will guide future treatment decisions.
Keywords:
PD-1PD-L1check point inhibitiongastroesophageal cancer

More Related Videos

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.6K
Establishment and Histological Analysis of Esophageal Organoids Modeling the Progression from Normal to Cancerous Tissues05:57

Establishment and Histological Analysis of Esophageal Organoids Modeling the Progression from Normal to Cancerous Tissues

Published on: May 30, 2025

1.1K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
1.5K
What is the Immune System?01:38

What is the Immune System?

Overview
132.4K
Esophageal Perforation-I: Introduction01:22

Esophageal Perforation-I: Introduction

Esophageal perforation is a severe medical condition characterized by a breach in the integrity of the esophageal wall. This breach can occur due to various factors such as trauma, medical procedures, or underlying diseases. When the esophageal wall is compromised, it allows food, fluids, and digestive juices into the chest cavity or adjacent structures, leading to potential complications and health risks.
The location of esophageal perforation can vary, occurring anywhere along the esophagus....
622
Esophageal Strictures-I: Introduction01:30

Esophageal Strictures-I: Introduction

Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
911
Marcia's Theory of Identity Status01:26

Marcia's Theory of Identity Status

James Marcia's identity status model provides a framework for understanding how adolescents navigate identity formation through varying degrees of exploration and commitment. Marcia's model builds on Erik Erikson's theories of psychosocial development, focusing specifically on how adolescents reconcile individual aspirations with societal expectations. His model describes identity formation as a dynamic process where adolescents move between different states depending on their level...
1.7K